Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Tuchman Alan J, Chairman & CEO. Insider active across 2 companies, notably Synaptogenix, Inc.. In total, 3 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €30k. Activity tracked since 13 July 2021. The latest transaction was disclosed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Alan J. Tuchman is the Chief Executive Officer of Synaptogenix, Inc. He leads the company and is responsible for its overall strategy. With significant experience in the biopharmaceutical sector, he is committed to promoting innovation and growth.